The Causes and Consequences of miR-503 Dysregulation and Its Impact on Cardiovascular Disease and Cancer
microRNAs (miRs) are short, non-coding RNAs that regulate gene expression by mRNA degradation or translational repression. Accumulated studies have demonstrated that miRs participate in various biological processes including cell differentiation, proliferation, apoptosis, metabolism and development,...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Frontiers Media S.A.,
2021-03-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_be3ca5e75b3f4c5da9fcd9ed7569a3c9 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Yanjing He |e author |
| 700 | 1 | 0 | |a Yin Cai |e author |
| 700 | 1 | 0 | |a Pearl Mingchu Pai |e author |
| 700 | 1 | 0 | |a Pearl Mingchu Pai |e author |
| 700 | 1 | 0 | |a Xinling Ren |e author |
| 700 | 1 | 0 | |a Zhengyuan Xia |e author |
| 700 | 1 | 0 | |a Zhengyuan Xia |e author |
| 700 | 1 | 0 | |a Zhengyuan Xia |e author |
| 245 | 0 | 0 | |a The Causes and Consequences of miR-503 Dysregulation and Its Impact on Cardiovascular Disease and Cancer |
| 260 | |b Frontiers Media S.A., |c 2021-03-01T00:00:00Z. | ||
| 500 | |a 1663-9812 | ||
| 500 | |a 10.3389/fphar.2021.629611 | ||
| 520 | |a microRNAs (miRs) are short, non-coding RNAs that regulate gene expression by mRNA degradation or translational repression. Accumulated studies have demonstrated that miRs participate in various biological processes including cell differentiation, proliferation, apoptosis, metabolism and development, and the dysregulation of miRs expression are involved in different human diseases, such as neurological, cardiovascular disease and cancer. microRNA-503 (miR-503), one member of miR-16 family, has been studied widely in cardiovascular disease and cancer. In this review, we summarize and discuss the studies of miR-503 in vitro and in vivo, and how miR-503 regulates gene expression from different aspects of pathological processes of diseases, including carcinogenesis, angiogenesis, tissue fibrosis and oxidative stress; We will also discuss the mechanisms of dysregulation of miR-503, and whether miR-503 could be applied as a diagnostic marker or therapeutic target in cardiovascular disease or cancer. | ||
| 546 | |a EN | ||
| 690 | |a microRNAs | ||
| 690 | |a microRNA-503 | ||
| 690 | |a cardiovascular disease | ||
| 690 | |a cancer | ||
| 690 | |a angiogenesis | ||
| 690 | |a oxidative stress | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Frontiers in Pharmacology, Vol 12 (2021) | |
| 787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fphar.2021.629611/full | |
| 787 | 0 | |n https://doaj.org/toc/1663-9812 | |
| 856 | 4 | 1 | |u https://doaj.org/article/be3ca5e75b3f4c5da9fcd9ed7569a3c9 |z Connect to this object online. |